- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02108041
Personlig medisin beslutningstaking i en virtuell klinisk setting
Medisinsk beslutningstaking i en virtuell klinisk setting
Background:
-How people respond to drugs depends in part on their genes. For some drugs, doctors can use an individuals genetic background to help in dosing the drug. Researchers want to know how doctors incorporate personalized or genomic medicine into clinical practice.
Objective:
-To study how physicians make personalized treatment decisions
Eligibility:
-Healthy adult primary care physicians who are internal (or family) medicine residents.
Design:
- Participants will complete a screening form.
- Participants will put on a headset, called a head-mounted display, showing a virtual reality environment.
- The environment will contain an exam room and the virtual patient.
- After interacting with the virtual patient, participants will complete a series of survey measures.
- Participation will last for about 60 minutes. The virtual patient interaction and follow-up questions will be audio taped.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
This study will examine factors related to primary care physicians clinical decision-making. Using a virtual clinical interaction experiment, we aim to better understand physicians decision-making processes and to explore their communication behaviors toward patients in the clinical encounter. Physician participants will enter a virtual exam room where they will be asked to respond to a virtual patient, acting as her primary care physician in a follow-up visit to evaluate her for depression. Various aspects of physician communication in the virtual clinic and self-report measures related to decision-making will be analyzed.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Maryland
-
Baltimore, Maryland, Forente stater, 21205
- Johns Hopkins School of Medicine
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02115
- Harvard School of Public Health
-
-
Michigan
-
Flint, Michigan, Forente stater
- Michigan State University
-
-
New York
-
New York, New York, Forente stater, 10032-3784
- Columbia University
-
-
Oregon
-
Eugene, Oregon, Forente stater
- University of Oregon
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Internal medicine and family medicine residents will be recruited from diverse national sites for the study, and the virtual reality environment will be brought to them through the use of a head-mounted display and laptop
Beskrivelse
- INCLUSION CRITERIA:
- All physicians will be healthy adult volunteers who are medical residents in the internal medicine specialty.
EXCLUSION CRITERIA:
- persons with seizure or vestibular disorders;
- persons who are highly prone to motion sickness;
- those without normal or normal to corrected vision or hearing;
- all current and past employees and contractors of NHGRI; and
- persons who have received information about the study purpose or procedure from a past participant.
NHGRI employees are excluded for this protocol because they are likely to have specialized genomic knowledge and may think differently about genomics in the clinical interaction.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: CASE_CONTROL
- Tidsperspektiver: CROSS_SECTIONAL
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Physicians that interact with the black/High SES avatar patien
Medical residents will then be randomized to be exposed to a virtual patient with one of 4 race/SES profiles, this one being a female patient who is Upper-Middle Income and Black/African American. |
|
Physicians that interact with the black/Low SES avatar patient
Medical residents will then be randomized to be exposed to a virtual patient with one of 4 race/SES profiles, this one being a female patient who is low-Middle Income and Black/African American. |
|
Physicians that interact with the white race/high SES avatar
Medical residents will then be randomized to be exposed to a virtual patient with one of 4 race/SES profiles, this one being a female patient who is Upper-Middle Income White andCaucasian. |
|
Physicians that interact with the white race/low SES avatar p
Medical residents will then be randomized to be exposed to a virtual patient with one of 4 race/SES profiles, this one being a female patient who is low Income White and Caucasian. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
To explore how physicians use genetic testing for anticoagulant (warfarin) dosage in patients of different racial/ethnic and SES backgrounds
Tidsramme: Outcome measurements are assessed on the same date of the study visit.
|
To explore how physicians use genetic testing for anticoagulant (warfarin) dosage in patients of different racial /ethnic and SES backgrounds |
Outcome measurements are assessed on the same date of the study visit.
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Susan J Persky, Ph.D., National Human Genome Research Institute (NHGRI)
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Green AR, Carney DR, Pallin DJ, Ngo LH, Raymond KL, Iezzoni LI, Banaji MR. Implicit bias among physicians and its prediction of thrombolysis decisions for black and white patients. J Gen Intern Med. 2007 Sep;22(9):1231-8. doi: 10.1007/s11606-007-0258-5. Epub 2007 Jun 27.
- Armstrong K. Genomics and health care disparities: the role of statistical discrimination. JAMA. 2012 Nov 21;308(19):1979-80. doi: 10.1001/2012.jama.10820. No abstract available.
Studierekorddatoer
Studer hoveddatoer
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Antatt)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 999914075
- 14-HG-N075
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
We will provide data contingent on special requests form other researchers.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .